Xinos Jaime 4
4 · ACHIEVE LIFE SCIENCES, INC. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Achieve Life Sciences (ACHV) CCO Jaime Xinos Receives 180,000-Share Option Award
What Happened
Jaime Xinos, Chief Commercial Officer of Achieve Life Sciences (ACHV), was granted a derivative award for 180,000 shares on January 28, 2026. The grant is reported at $0.00 (no cash paid) and is recorded as a derivative security (an option award). This is an award/grant rather than a purchase or sale.
Key Details
- Transaction date: January 28, 2026; reported consideration: $0.00 per share (derivative award).
- Quantity: 180,000 shares (option award).
- Vesting: 25% vests on the first anniversary and the remainder vests in substantially equal monthly installments over the next 36 months (see footnote F1).
- Shares owned after the transaction: Not disclosed on the Form 4.
- Filing: Form 4 was filed January 30, 2026 (appears to be filed within the typical two-business-day window).
Context
This was a time‑based option award to an executive, not an open‑market buy or sale. The award vests over four years, so the shares are not immediately owned or liquid; exercise and any subsequent sale would occur only as portions vest and subject to the plan’s terms. Awards like this are common for executive compensation and do not by themselves indicate an immediate bullish or bearish trading signal.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-01-28+180,000→ 180,000 totalExercise: $4.36Exp: 2036-01-28→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.